Literature DB >> 180015

Biosynthesis of adrenocorticotropic hormone in mouse pituitary tumor cells.

R E Mains, B A Eipper.   

Abstract

A double antibody immunoprecipitation technique using affinity-purified adrenocorticotropic hormone (ACTH) antiserum was employed to investigate the biosynthesis of ACTH in a mouse pituitary tumor cell line. Sodium dodecyl sulfate polyacrylamide gel electrophoresis of cell extracts resolved four forms of ACTH with apparent molecular weights of 4,500, 13,000, 23,000, and 31,000. These four forms of ACTH can be detected by radioimmunoassay of cell extracts or by immunoprecipitation of cell extracts following incubation of cultures in [3H] tryptophan, [3H] lysine, or [3H] tyrosine. The double antibody immunoprecipitation scheme developed is specific, quantitative, and reproducible. ACTH biosynthesis was examined in both steady and pulse-labeling experiments using [8H] tyrosine or [3H] lysine. The results of these experiments are consistent with the proposal that Mr=31,000 ACTH is the biosynthetic precursor for all three smaller forms of ACTH and that Mr=23,000 ACTH is a biosynthetic intermediate. Both Mr=13,000 ACTH and Mr=4,500 ACTH are derived from the intracellular processing of Mr=31,000 ACTH.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180015

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Characterisation of ACTH related peptides in ectopic Cushing's syndrome.

Authors:  Robert L Oliver; Julian R E Davis; Anne White
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 2.  The enkephalins. Peptides with morphine-like activity.

Authors:  R J Miller; P Cuatrecasas
Journal:  Naturwissenschaften       Date:  1978-10

3.  Construction of bacterial plasmids that contain the nucleotide sequence for bovine corticotropin-beta-lipotropin precursor.

Authors:  S Nakanishi; A Inoue; T Kita; S Numa; A C Chang; S N Cohen; J Nunberg; R T Schimke
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

4.  Isolation, characterization, and synthesis of a corticotropin-inhibiting peptide from human pituitary glands.

Authors:  C H Li; D Chung; D Yamashiro; C Y Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

5.  Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia.

Authors:  P Crine; C Gianoulakis; N G Seidah; F Gossard; P D Pezalla; M Lis; M Chrétien
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

6.  Immunological evidence for two common precursors to corticotropins, endorphins, and melanotropin in the neurointermediate lobe of the toad pituitary.

Authors:  Y P Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  In vitro synthesis of pre-proteins of vacuolar compartmented proteinase inhibitors that accumulate in leaves of wounded tomato plants.

Authors:  C E Nelson; C A Ryan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  Kalirin/Trio Rho guanine nucleotide exchange factors regulate a novel step in secretory granule maturation.

Authors:  Francesco Ferraro; Xin-Ming Ma; Jacqueline A Sobota; Betty A Eipper; Richard E Mains
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

9.  Characterization of a common precursor to corticotropin and beta-lipotropin: cell-free synthesis of the precursor and identification of corticotropin peptides in the molecule.

Authors:  J L Roberts; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

10.  Characterization of a common precursor to corticotropin and beta-lipotropin: identification of beta-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cell-free system.

Authors:  J L Roberts; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.